Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-02-03, Stock:ABBV, The news for the past five days is as follows:
2020-01-27: NEWS1: 3 Biotech Stocks Are Soaring Because Everyone Wants a Coronavirus Vaccine.NEWS2: Dow ends more than 450 points lower as spread of coronavirus quashes buying sentiment.NEWS3: The Key Move AbbVie Just Made To Help It Clinch A $63 Billion Deal.NEWS4: Jim Cramer: 6 Stocks to Buy on Coronavirus Fears.NEWS5: Form 8.3 - Abbvie Plc - Amendment.NEWS6: Allergan to divest two drugs, to move forward with AbbVie deal.NEWS7: 3 Top Dividend Stocks to Maximize Your Retirement Income - January 27, 2020.NEWS8: Dow Tumbles as Spreading Coronavirus Makes Wall Street Jittery.NEWS9: The Market Timing Secrets No One Talks About - January 27, 2020.NEWS10: AbbVie Announces Extension of Expiration Date for Exchange Offers for Allergan Notes.NEWS11: Trading AbbVie as Its Drug Is Seen as Possible Coronavirus Treatment.NEWS12: Why AbbVie Looks Like a Bargain at These Levels.NEWS13: Stocks Fall Sharply as Wall Street Weighs Economic Impact of Coronavirus.NEWS14: AbbVie HIV Drugs Being Tested as Possible Coronavirus Antidote.NEWS15: Allergan Sells Drugs to Nestle and AstraZeneca Ahead of AbbVie Tie-Up.NEWS16: Stocks Sink as Wall Street Weighs Economic Impact of Coronavirus.NEWS17: AbbVie-Allergan $63 billion deal aided by Nestle, AstraZeneca buys.NEWS18: A Technical Strategy for AbbVie as the Broad Market Gets Rocked.NEWS19: AbbVie and Allergan Announce Agreements to Divest Brazikumab and Zenpep.
2020-01-28: NEWS1: AbbVie (ABBV) Stock Sinks As Market Gains: What You Should Know.NEWS2: China's coronavirus outbreak: Here's what happened on Tuesday.NEWS3: Form 8.3 - Abbvie Plc - Amendment.NEWS4: Allergan to Divest Brazikumab, Zenpep to Close AbbVie Merger.NEWS5: Johnson & Johnson Is the Quintessential Recession-Proof Company.NEWS6: Alector Announces Initiation of Phase 1b Study of AL003 in Alzheimer’s Disease Patients.NEWS7: Form 8.3 - ABBVIE INC.
2020-01-29: NEWS1: Joel Greenblatt: Is There Still an Edge to Be Found in the Market?.NEWS2: Form 8.3 - ABBVIE INC.
2020-01-30: NEWS1: J&J (JNJ) Plans to Develop Vaccine for New Coronavirus.NEWS2: Coronavirus update: US records first human-to-human transmission as WHO declares global emergency.NEWS3: Biogen (BIIB) Surpasses Q4 Earnings and Sales Estimates.NEWS4: Form 8.3 - Abbvie Plc - Amendment.NEWS5: Form 8.3 - ABBVIE INC - Amendment.NEWS6: FORM 8.3 - ABBVIE PLC.NEWS7: Slapping Around Martin Shkreli Won’t Cut Drug Prices.
2020-01-31: NEWS1: Lilly's Olumiant Succeeds in Another Late-Stage Eczema Study.NEWS2: Form 8.3 - Abbvie Plc.NEWS3: Amgen (AMGN) Stock Down Despite Q4 Earnings & Revenue Beat.NEWS4: Decisions, Decisions: AbbVie or Bristol-Myers Squibb?.NEWS5: AbbVie Receives Positive CHMP Opinion for MAVIRET® (glecaprevir/pibrentasvir) to Shorten Treatment Duration to Eight Weeks in Genotype 3, Treatment-Naïve Patients with Chronic Hepatitis C and Compensated Cirrhosis.NEWS6: AbbVie Receives Positive CHMP Opinion for VENCLYXTO® as a Chemotherapy-Free Combination Regimen for Patients with Previously Untreated Chronic Lymphocytic Leukemia.

Answer: Rise